# Bernard Rubin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bernard-rubin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,430 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 26 |
| i10-index | 37 |
| Last Known Institution | Oklahoma City University |
| OpenAlex ID | https://openalex.org/A5043253271 |
| ORCID iD | 0000-0002-9250-3865 |
| Works | 81 |

## Researcher papers

- [Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents](https://scholariq.org/papers/design-of-specific-inhibitors-of-angiotensin-converting-enzyme-new-class-of/)
- [Production and Evaluation of Antibodies for the Radioimmunoassay of Gastrin](https://scholariq.org/papers/production-and-evaluation-of-antibodies-for-the-radioimmunoassay-of-gastrin/)
- [SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.](https://scholariq.org/papers/sq-14-225-d-3-mercapto-2-methylpropanoyl-l-proline-a-novel-orally-active/)
- [Cholecystokinin-pancreozymin](https://scholariq.org/papers/cholecystokinin-pancreozymin/)
- [Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.](https://scholariq.org/papers/antihypertensive-activity-in-rats-for-sq-14-225-an-orally-active-inhibitor-of/)
- [Inhibition of Pressor Effects of Angiotensin I and Augmentation of Depressor Effects of Bradykinin by Synthetic Peptides](https://scholariq.org/papers/inhibition-of-pressor-effects-of-angiotensin-i-and-augmentation-of-depressor/)
- [BIOASSAY OF RAUWOLFIA ROOTS AND ALKALOIDS](https://scholariq.org/papers/bioassay-of-rauwolfia-roots-and-alkaloids/)
- [Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent](https://scholariq.org/papers/captopril-sq-14-225-d-3-mercapto-2-methylpropanoyl-l-proline-a-novel-orally/)
- [EFFECTS OF CHRONIC TREATMENT WITH CAPTOPRIL(SQ 14,225), AN ORALLY ACTIVE INHIBITOR OFANGIOTENSIN I-CONVERTING ENZYME, INSPONTANEOUSLY HYPERTENSIVE RATS](https://scholariq.org/papers/effects-of-chronic-treatment-with-captopril-sq-14-225-an-orally-active-inhibitor/)
- [Effects of Captopril in Animal Models of Hypertension](https://scholariq.org/papers/effects-of-captopril-in-animal-models-of-hypertension/)
- [Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis](https://scholariq.org/papers/healthcare-resource-utilization-and-associated-costs-in-patients-with-systemic/)
- [Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period](https://scholariq.org/papers/healthcare-resource-utilization-and-costs-in-patients-with-a-newly-confirmed/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Protein Hydrolysis and Bioactive Peptides](https://scholariq.org/topics/protein-hydrolysis-and-bioactive-peptides/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [Oklahoma City University](https://scholariq.org/institutions/oklahoma-city-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.